Osaic Holdings’s Meridian Bioscience Inc VIVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-7,433
Closed -$246K 7692
2022
Q4
$246K Sell
7,433
-1,174
-14% -$37.8K ﹤0.01% 3673
2022
Q3
$272K Sell
8,607
-41,497
-83% -$1.34M ﹤0.01% 3468
2022
Q2
$1.52M Buy
50,104
+33,651
+205% +$910K ﹤0.01% 1878
2022
Q1
$464K Buy
16,453
+940
+6% +$22.4K ﹤0.01% 3295
2021
Q4
$316K Sell
15,513
-597
-4% -$11.4K ﹤0.01% 3514
2021
Q3
$310K Sell
16,110
-1,407
-8% -$28K ﹤0.01% 3516
2021
Q2
$388K Sell
17,517
-14,142
-45% -$300K ﹤0.01% 3274
2021
Q1
$831K Buy
31,659
+17,693
+127% +$421K ﹤0.01% 2398
2020
Q4
$261K Buy
13,966
+1,800
+15% +$33.6K ﹤0.01% 3235
2020
Q3
$207K Buy
12,166
+10,266
+540% +$200K ﹤0.01% 3225
2020
Q2
$44K Buy
1,900
+400
+27% +$5.8K ﹤0.01% 4278
2020
Q1
$13K Buy
+1,500
New +$12.6K ﹤0.01% 4888

Other funds holding VIVO

Osaic Holdings's VIVO Position: Q1 2023 in Review

Osaic Holdings sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 7,433 shares — an estimated $246K sold.

Osaic Holdings first reported a position in VIVO in Q1 2020 and held it in 12 quarters. The position peaked at $1.52M in Q2 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Osaic Holdings reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Osaic Holdings sold 7,433 Meridian Bioscience Inc shares in Q1 2023, an estimated $246K.
  • Osaic Holdings first reported a position in Meridian Bioscience Inc in Q1 2020 and held it in 12 quarters.
  • Osaic Holdings's Meridian Bioscience Inc position peaked at $1.52M in Q2 2022.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Osaic Holdings's 13F filing for Q1 2023, filed 12 May 2023.